Informação sobre produto
Nome:
Ladostigil tartrate
Sinónimos:
- N-Ethyl-N-methylcarbamic acid (3R)-2,3-dihydro-3-(2-propyn-1-ylamino)-1H-inden-5-yl ester (2R,3R)-2,3-dihydroxybutanedioateTV 3326
- (3R)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-yl ethyl(methyl)carbamate 2,3-dihydroxybutanedioate (2:1)
- Carbamic acid, N-ethyl-N-methyl-, (3R)-2,3-dihydro-3-(2-propyn-1-ylamino)-1H-inden-5-yl ester, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- Carbamic acid, ethylmethyl-, (3R)-2,3-dihydro-3-(2-propynylamino)-1H-inden-5-yl ester, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- Ethylmethyl-carbamic acid (3R)-2,3-dihydro-3-(2-propynylamino)-1H-inden-5-yl ester (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- Tv 3326
Descrição:
Ladostigil tartrate is an aminopyridine drug that has been used to treat neurodegenerative diseases, such as Alzheimer's disease. Ladostigil tartrate is a pro-drug of carbamic acid and butyrylcholinesterase inhibitor. This medication binds to the active site of acetylcholine esterase (AChE) and blocks its activity. This allows more acetylcholine to accumulate in the synapses, which results in increased stimulation of postsynaptic receptors. Ladostigil tartrate also has neuroprotective effects and has been shown to reduce microglial activation and pro-inflammatory cytokines in mice models for Alzheimer's disease.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
347.39 g/mol
Fórmula:
C18H23N2O5
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
